Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)

Published:2004-09-09 Issue:10 Volume:18 Page:1605-1610
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wiernik P H, ,Paietta E,Goloubeva O,Lee S J,Makower D,Bennett J M,Wade J L,Ghosh C,Kaminer L S,Pizzolo J,Tallman M S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403494.pdf

Reference43 articles.

1. Banner KH, Page CP . Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors. Clin Exp Allergy 1996; 26 (Suppl. 2): 2–9.

2. Chung KF . Theophylline in chronic asthma – evidence for disease – modifying properties. Clin Exp Allergy 1996; 26 (Suppl. 2): 22–27.

3. Scordamaglia A, Ciprandis G, Ruffoni S, Caria M, Paolieri F, Venuti D et al. Theophylline and the immune response: in vivo and in vitro effects. Clin Immunol Immunopath 1988; 48: 238–246.

4. Jaffar Z, Sullivan P, Page CP, Costello J . Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur Resp J 1996; 9: 456–462.

5. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ . Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Resp Critical Care Med 1995; 151: 1907–1914.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-04

2. Reactive oxygen species–dependent upregulation of death receptor, tumor necrosis factor receptor 1, is responsible for theophylline-mediated cytotoxicity in MDA-MB-231 breast cancer cells;Anti-Cancer Drugs;2022-08-10

3. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics;Vaccines;2021-01-27

4. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity;Seminars in Cancer Biology;2021-01

5. A2B Adenosine Receptor and Cancer;International Journal of Molecular Sciences;2019-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3